	Severe Sunburns and Sunbed Use Risk with Cutaneous Melanoma: A Case-Control Study in Lithuania. Medicina (Kaunas) Butrimas G, , Pauk, Dubinskait, Janonyt, Luk, Valiukevi. PMID: 41303778 [PubMed - indexed for MEDLINE]
	Pathway-Specific Therapeutic Modulation of Melanoma: Small-Molecule Inhibition of BRAF-MEK and KIT Signaling in Contemporary Precision Oncology with a Special Focus on Vemurafenib, Trametinib, and Imatinib. J Clin Med Kawczak P, B. PMID: 41302945 [PubMed]
	From Slide to Insight: The Emerging Alliance of Digital Pathology and AI in Melanoma Diagnostics. Cancers (Basel) Venturi F, Veronesi G, Gualandi A, Magnaterra E, Scotti B, Sotiri I, Baraldi C, Alessandrini AM, Veneziano L, Vaccari S, Cama EM, Tassone D, Corti B, Dika E. PMID: 41301061 [PubMed]
	Prognostic Significance of Endocrine-Related Adverse Events in Patients with Melanoma, Non-Small Cell Lung Cancer and Urothelial Cancer After Treatment with Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis. Cancers (Basel) Kopanos S, Filippatos C, Rousakis P, Kostopoulos IV, Baxevanis CN, Tentolouris A, Gavriatopoulou M, Tsitsilonis O, Ntanasis-Stathopoulos I. PMID: 41301042 [PubMed]
	Cigarette Smoking and Survival of Patients with Non-Melanoma Skin Cancer: A Systematic Literature Review and Meta-Analysis. Cancers (Basel) Andreon C, Gaeta A, Carretti M, Graziani A, Tosti G, Doccioli C, Saponara M, Gorini G, Suppa M, Di Maggio E, Gandini S, Caini S. PMID: 41301036 [PubMed]
	KIT-Mutant Melanoma: Understanding the Pathway to Personalized Therapy. Cancers (Basel) Kaveti A, Sullivan RJ, Tsao H. PMID: 41301010 [PubMed]
	Contrasting Survival Outcomes and Patient Characteristics in 5,815 Patients with Stage II and III Melanoma: A Nationwide Population-Based Registry Study from Sweden. Br J Dermatol Marjanovic M, Mikiver R, Nielsen K, Isaksson K, Claeson M. PMID: 41296675 [PubMed - as supplied by publisher]
	Antibiotic Exposure Does Not Impact Anti-BRAF/Anti-MEK Targeted Therapy Outcome in Patients with Advanced Melanoma. Curr Oncol Wang YS, Wang QY, Moise AE, Syed HC, Malo J, Soberano S, Belkaid W, Messaoudene M, Bélanger K, Desilets A, Jamal R, Routy B, Elkrief A. PMID: 41294692 [PubMed - indexed for MEDLINE]
	Insights into shape of uveal melanoma: a comprehensive evaluation of clinical features, pathological features, and prognosis analysis. Front Med (Lausanne) Lou H, Yue H, Qian J, Bi Y, Lin X, Chen H, Xu B, Ma R, Xue K, Guo J. PMID: 41293718 [PubMed]
	Global Burden of Non-Melanoma Skin Cancer Among Elder Adults and Projections to 2071: A Systematic and Comprehensive Analysis of the Global Burden of Disease Study 2021. Clin Cosmet Investig Dermatol Wang C, Du Z, Tan Y, Yang Z, Hua J, Wang G, Li T. PMID: 41293322 [PubMed]
	Serum lactate dehydrogenase and rapidly progressive interstitial lung disease are associated with increased mortality in anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis. Front Immunol Wang G, Yan D, Zhang Y, Liu C, Liu Z. PMID: 41293179 [PubMed - indexed for MEDLINE]
	Impact of comorbidities on survival in melanoma patients. BMC Cancer Buja A, Cassalia F, Rugge M, Trevisiol C, Zorzi M, Del Fiore P, Pantaleo I, Rossi CR, Conte P, Belloni Fortina A, Mocellin S. PMID: 41291616 [PubMed - as supplied by publisher]
	Neoadjuvant plus adjuvant dabrafenib and trametinib versus adjuvant dabrafenib and trametinib in patients with stage III melanoma: a single-center retrospective cohort study. J Dermatolog Treat Jia DD, Li T. PMID: 41290590 [PubMed - indexed for MEDLINE]
	"Response to Factors associated with adherence to skin self-examination recommendations for melanoma patients: a prospective cohort study". J Am Acad Dermatol Gill M, Yang S, Kim D, Babaei N, Cervantes M, Wu JJ. PMID: 41285263 [PubMed - as supplied by publisher]
	Does tattoo exposure increase the risk of cutaneous melanoma? A population-based case-control study. Eur J Epidemiol Rietz Liljedahl E, Nielsen K, Engfeldt M, Saxne Jöud A, Nielsen C. PMID: 41284183 [PubMed - as supplied by publisher]
	Is Radiotherapy a Risk Factor for Melanoma? Dermatopathology (Basel) Ozer S, Agarwal P, Musolff N, Plann-Curley B, Cosgun G, Sun HY, Rao B. PMID: 41283485 [PubMed]
	Translating Features to Findings: Deep Learning for Melanoma Subtype Prediction. Dermatopathology (Basel) Guermazi D, Khemchandani S, Wahood S, Nguyen C, Saliba E. PMID: 41283484 [PubMed]
	The mediating role of rumination between fear of disease progression and sleep disturbance in melanoma patients: a dual-perspective analysis based on person-centered and variable-centered approaches. Front Public Health Huang Q, Yue F, Shi W, Lei Y, Jiang T. PMID: 41283030 [PubMed - indexed for MEDLINE]
	Lead-in therapy targeting PD1 and/or LAG3 imposes distinct immune phenotypes in first-line treatment of metastatic melanoma. medRxiv Karapetyan L, Cillo AR, Wang S, Karunamurthy A, Massa RC, Rohatgi A, Deitrick C, Najjar YG, Davar D, Luke JJ, Sander C, Kunning SR, Rose A, Bradley S, Rush E, Joy M, Bao R, Wang H, Vignali DAA, Bruno TC, Kirkwood JM. PMID: 41282765 [PubMed]
	Deep learning [(18)F]-FDG-PET/CTâ€‘based algorithm for tumor burden estimation in metastatic melanoma patients under immunotherapy. Clin Transl Radiat Oncol Faro LL, Gabry, Burgermeister S, Abler D, Fritsak M, Ahmadsei M, Franzese C, Depeursinge A, Cuendet MA, Tanadini-Lang S, Balermpas P, Scorsetti M, Guckenberger M, Christ SM. PMID: 41281625 [PubMed]

Articles 1 - 20 / 44257

Page 1 of 2213



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy